Table 2

Number of subjects autoantibody positive and screened/rescreened by specific autoantibody

Rescreening: number autoantibody positive/number screened (%)
Screen 1 (initial)2345678Total seroconversions/rescreens
ICA1,454/42,447 (3.4)151/11,813 (1.3)47/5,306 (0.9)42/2,532 (1.7)7/1,165 (0.6)10/564 (1.8)1/220 (0.5)0/71 (0)258/21,671 (1.2)
GAD65*1,758/42,447 (4.1)134/11,522 (1.2)58/5,126 (1.1)23/2,410 (1.0)11/1,118 (1.0)2/532 (0.4)4/212 (1.9)1/101 (1.0)234/21,021 (1.1)
ICA512*899/42,447 (2.1)54/11,614 (0.5)15/5,243 (0.3)14/2,538 (0.6)6/1,188 (0.5)5/585 (0.9)1/240 (0.4)2/151 (1.3)99/21,559 (0.5)
mIAA1,094/42,447 (2.6)
  • Data are N (%).

  • *GAD65 and ICA512 were measured on 98% of those that returned for a rescreening.

  • †Rescreening not evaluated in this study.